- NIA Academic Leadership Career Award (K07 Independent Clinical Trial Not Allowed)
- Population Approaches to Reducing Alcohol-related Cancer Risk (R01 Clinical Trial Optional)
- Stimulating Hematology Investigation: New Endeavors (SHINE) (R01 Clinical Trial Not Allowed)
- Bioengineering Partnerships with Industry (U01 Clinical Trial Optional)
- Research Projects to Enhance Applicability of Mammalian Models for Translational Research (R01 Clinical Trial Not Allowed)
- BRAIN Initiative: Clinical Studies to Advance Next-Generation Devices for Recording and Modulation in the Human Central Nervous System (UH3 Clinical Trial Optional)
- BRAIN Initiative: Next-Generation Devices for Recording and Modulation in the Human Central Nervous System (UG3/UH3 Clinical Trial Optional)
- Cancer Prevention and Control Clinical Trials Planning Grant Program (R34 Clinical Trials Optional)
- Cancer Prevention and Control Clinical Trials Planning Grant Program (U34 Clinical Trials Optional)
- Extravehicular Activity and Human Surface Mobility Technologies - A New Partnering Opportunity
- Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Neurotherapeutic Agent Characterization and In vivo Efficacy Studies (R61/R33 Clinical Trial Not Allowed)
- CCRP Initiative: NIH Countermeasures Against Chemical Threats (CounterACT) Basic Research on Chemical Threats that Affect the Nervous System (R01 Clinical Trial Not Allowed)
- 2023 Light Duty Vocational Trucks
- Dissemination and Implementation Research in Health (R21 Clinical Trial Optional)
- Effectiveness Trials for Post-Acute Interventions and Services to Optimize Longer-term Outcomes (R01 Clinical Trial Required)
- Open Source Software: MOOSE: The Multiphysics Simulation Powerhouse
- Pilot Effectiveness Trials for Post-Acute Interventions and Services to Optimize Longer-term Outcomes (R01 Clinical Trial Required)
- Supply Blanket Purchase Agreement (Hardware)
- Enhancing Mechanistic Research on Precision Probiotic Therapies (R33 Clinical Trial Optional)
- Enhancing Mechanistic Research on Precision Probiotic Therapies (R61/R33 Clinical Trial Optional)
- Biomedical Research Environment and Sponsored Programs Administration Development (BRE-SPAD) Program (UC2- Clinical Trial Not Allowed)
- Dissemination and Implementation Research in Health (R03 Clinical Trial Not Allowed)
- FY25 CMC Naphcare
- Screening and Functional Validation of Genomic Variants Associated with Human Congenital Anomalies (R01 Clinical Trial Not Allowed)
- WA ERFO NPS MORA 2022-1(1), Mount Rainier ERFO Repairs 2022
- Computational Approaches to Curation at Scale for Biomedical Research Assets (R01 Clinical Trial Not Allowed)
- Dissemination and Implementation Research in Health (R01 Clinical Trial Optional)
- Translational Neural Devices (R61/R33 - Clinical Trial Optional)
- Development of Biomarkers or Composite Biomarkers for Neurological and Neuromuscular Disorders (R61/R33 - Clinical Trial Optional)
- Limited Competition: Renewal of Existing NINDS-Supported Clinical Trial Cooperative Agreement Awards (U01 - Clinical Trials Required)
- Pilot Projects Investigating Understudied Proteins Associated with Rare Diseases (R03 Clinical Trial Not Allowed)
- BRAIN Initiative: Brain Behavior Quantification and Synchronization- Next Generation Sensor Technology Development (U01 Clinical Trial Optional)
- NIDCR Drug, Biologic, Device and/or Procedure Intervention Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)
- Strategic Capabilities Office Broad Agency Announcement
- Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Assay Development and Neurotherapeutic Agent Identification (R61/R33 Clinical Trial Not Allowed)
- Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Development and Validation of Model Systems to Facilitate Neurotherapeutic Discovery (R61/R33 Clinical Trial Not Allowed)
- NIDCD Early Career Research(ECR) Award (R21 Clinical Trial Optional)
- C5ISR Center MOSA Management Office (MMO) for CMOSS / VICTORY / MORA
- Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH3 Clinical Trials Not Allowed)
- Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed)
- Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 Clinical Trial Not Allowed)
- Emerging Global Leader Award (K43 Independent Clinical Trial Required)
- Continuation or Revision of NIDCR Clinical Trial Planning and Implementation Cooperative Agreement (UH3 Clinical Trial Required)
- Interventions to expand cancer screening and preventive services to ADVANCE health in populations that experience health disparities (R01, Clinical Trial Required)
- Revision Applications for Validation of Biomarker Assays Developed Through NIH-Supported Research Grants (R01 Clinical Trial Not Allowed)
- W56KGU-22-R-0ESI BAA Amendment 08
- FY 2024 – 2026 Broad Agency Announcement (BAA), Office of Oceanic and Atmospheric Research (OAR)
- Cultural Anthropology Program Senior Research Awards
- Dimethyl Fumarate DR Presolicitation
- Occupational Safety and Health Education and Research Centers (T42)
- Limited Competition: CCRP Initiative: Promoting a Basic Understanding of Chemical Threats to Skin (R34 Clinical Trial Not Allowed)
- Intro to DIA for Small Businesses
- Research Experiences and/or Mentoring Networks through Research Education to Enhance Clinician-Scientists' Participation in NIDCDs Research (R25 Clinical Trial Not Allowed)
- Seeding Critical Advances for Leading Energy Technologies With Untapped Potential (Scaleup) Ready
- Broad Other Transaction Authority Announcement (BOTAA) for Military Engineering and Engineered Resilient Systems
- Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional)
- Fundamental Research to Counter Weapons of Mass Destruction
- NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed)
- BPA - Gases: Compressed and Liquefied PSC 68--
- DHA Operations and Maintenance Multiple Award Task Order Contract (MATOC) AOR 1 and AOR 2
- Signals Information Exploitation Technology Enhancements (SIETE)
- The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Seeks Industry Partners for Clinical Research Collaborations on Therapeutics, Diagnostics or Devices for Childhood Cholestatic Liver Diseases
- Next Space Technologies for Exploration Partnerships -3 (NextSTEP-3) Omnibus
- RESTORE Act Centers of Excellence Research Grants Program
- RESTORE Act Direct Component - Non-Construction Activities
- RESTORE Act Direct Component – Construction and Real Property Acquisition Activities
- Tanker Truck Fuel Pick-up
- BRAIN Initiative: Reagent Resources for Brain Cell Type-Specific Access to Broaden Distribution of Enabling Technologies for Neuroscience (U24 Clinical Trial Not Allowed)
- Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development of Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional)
- NICHD Resource Program Grants in Bioinformatics (P41 Clinical Trial Not Allowed)
- F--Techlaw Environmental Services and Operations (ESO
- SPRRA224R0088 MLRS Spares
- HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allowed)
- HC-144 & HC-27J Inverter Repair
- Imaging - Science Track Award for Research Transition (I/START) (R03 Clinical Trial Optional)
- F--Process Fluid Stabilization, Denton-Rawhide Mine, Mineral County, Nevada
- Automated Processes for Knowledge Discovery and Information Retrieval
- Manufacturing Demonstration Facility: Technology Collaborations for US Manufacturers in Advanced Manufacturing and Materials Technologies
- Mechanisms that Impact Cancer Risk after Bariatric Surgery (R01 Clinical Trial Optional)
- Mechanisms that Impact Cancer Risk after Bariatric Surgery (R21 Clinical Trial Not Allowed)
- AN_APG66_Transmitter_NSN5960014448163_PN588R901H02_ElectronTube
- Clinical and Translational Science Award (UM1 Clinical Trial Optional)
- Transportation Security Administration’s Open Architecture Initiatives
- Tribal Undergraduate to Graduate Research Training and Leadership Experiences (TURTLE) Program (UE5/T32)
- Tribal Undergraduate to Graduate Research Training and Leadership Experiences (TURTLE) Program (UE5/T34)
- FY24-28 D01 BTOOLKIT(ITD) Huntsville & Tuscaloosa Comcast
- Award SPRRA124C0024
- Advancing Healthcare for Older Adults from Populations that Experience Health Disparities (R01 - Clinical Trial Optional)
- 2024-08-22 OIG Letter to EPA Contractors
- Forest Improvement Herbicide- Fort Drum
- Job Corps Center Operations Procurement Plan
- Mid-scale Research Infrastructure-1
- FY 2024 – 2026 - Broad Agency Announcement (BAA) Announcement Type: Initial
- U.S. National Science Foundation Research Traineeship (NRT) Program
- FY 2024 – 2026 - Broad Agency Announcement (BAA) Announcement Type: Initial
- NIDA Animal Genomics Program (U01 Clinical Trial Not Allowed)
- FY 2024 – 2026 - Broad Agency Announcement (BAA) for the Office of Education
- Tribal Institutional Review Board Establishment and Enhancement (TIRBEE) (R24 - Clinical Trial Not Allowed)
- Broad Agency Announcement DEVCOM C5ISR ESI
- High Priority HIV and Substance Use Research (R01 Clinical Trial Optional)